Proportion of cases and controls with novel surface HLA-DRB1–tFVIII peptide binding combinations by mutation
| . | Controls with >10 novel surface HLA-DRB1–tFVIII peptide binding combinations . | Cases with >10 novel surface HLA-DRB1–tFVIII peptide binding combinations . |
|---|---|---|
| High-risk mutation | 5 (62.5) | 11 (78.6) |
| Other | 6 (20.7) | 2 (33.3) |
| . | Controls with >10 novel surface HLA-DRB1–tFVIII peptide binding combinations . | Cases with >10 novel surface HLA-DRB1–tFVIII peptide binding combinations . |
|---|---|---|
| High-risk mutation | 5 (62.5) | 11 (78.6) |
| Other | 6 (20.7) | 2 (33.3) |
Data are n (%). High-risk mutation is p.Arg162Cys, p.Asn1941Ser, p.Arg2169His, p.Trp2248Cys.